pyrimethamine has been researched along with Porphyria Cutanea Tarda in 1 studies
Maloprim: contains above 2 cpds
Porphyria Cutanea Tarda: An autosomal dominant or acquired porphyria due to a deficiency of UROPORPHYRINOGEN DECARBOXYLASE in the LIVER. It is characterized by photosensitivity and cutaneous lesions with little or no neurologic symptoms. Type I is the acquired form and is strongly associated with liver diseases and hepatic toxicities caused by alcohol or estrogenic steroids. Type II is the familial form.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belda Mira, A | 1 |
| Rovira Daudí, E | 1 |
| Díaz Sánchez, F | 1 |
| Michavila Gómez, J | 1 |
1 other study available for pyrimethamine and Porphyria Cutanea Tarda
| Article | Year |
|---|---|
[Porphyria cutanea tarda and human immunodeficiency virus infection. Apropos of 2 further cases].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Chloroquine; Drug Therapy, Combination; HIV Infectio | 1994 |